Hoya Corp ( (HOCPY) ) has released its Q3 earnings. Here is a breakdown of the information Hoya Corp presented to its investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Hoya Corporation is a global leader in the fields of healthcare and information technology, known for its innovative solutions in optical products, healthcare equipment, and electronics. The company operates across two main business segments: Life Care and Information Technology, offering products such as eyeglass and contact lenses, medical devices, and semiconductor-related products.
In its latest earnings report for the third quarter ending December 31, 2024, Hoya Corp reported a notable increase in both revenue and profit. The company achieved a 13.4% increase in revenue, reaching 220,845 million yen, and a 31.3% rise in profit before tax, totaling 65,224 million yen. These results reflect strong performance across its business segments, particularly in the Information Technology sector, which saw a 33.3% surge in revenue.
Key financial highlights include a substantial 30.2% increase in profit for the quarter, amounting to 50,740 million yen, and a 30.6% increase in profit attributable to the company’s owners. Basic earnings per share rose to 145.35 yen. The Life Care segment experienced a modest 4.4% revenue growth, while the Information Technology segment demonstrated robust growth, driven by demand for semiconductor mask blanks and imaging products.
Hoya’s financial position remains strong with total assets increasing to 1,278,687 million yen and total equity reaching 1,014,755 million yen as of December 31, 2024. The company generated significant free cash flow of 46,606 million yen, reflecting efficient operational management.
Looking ahead, Hoya Corp maintains a positive outlook with projected full-year revenue expected to increase by 14.0% to 869,200 million yen. The management is focused on leveraging its strengths in digital and healthcare technologies to drive sustainable growth and shareholder value.
